Clinical Trial Update: CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating capecitabine before tumor resection in head and neck cancers; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Laryngeal Cancer
• Oral Cancer
• Pharyngeal Cancer
• Skin Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Head Neck Cancer, Mouth Cancer | Phase 2 | Status: NOT_YET_RECRUITING